pyrazolanthrone has been researched along with thimerosal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dhar, S; Herdman, ML; Huang, Y; Kiningham, KK; Marcelo, A; Niles, RM | 1 |
Chang, PM; Chen, WC; Chou, CT; Chu, ST; Fang, YC; Huang, CC; Huang, CJ; Jan, CR; Liu, SI; Lu, YC; Wang, BW; Wang, JL | 1 |
2 other study(ies) available for pyrazolanthrone and thimerosal
Article | Year |
---|---|
Thimerosal induces apoptosis in a neuroblastoma model via the cJun N-terminal kinase pathway.
Topics: Anthracenes; Apoptosis; Cell Line, Tumor; Enzyme Inhibitors; Humans; JNK Mitogen-Activated Protein Kinases; Neuroblastoma; Phosphorylation; Thimerosal; Transcription Factor AP-1 | 2006 |
Thimerosal-induced apoptosis in human SCM1 gastric cancer cells: activation of p38 MAP kinase and caspase-3 pathways without involvement of [Ca2+]i elevation.
Topics: Anthracenes; Apoptosis; Calcium Signaling; Caspase 3; Cell Line, Tumor; Cell Survival; Chelating Agents; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Preservatives, Pharmaceutical; Protein Kinase Inhibitors; Pyridines; Stomach Neoplasms; Thimerosal; Time Factors | 2007 |